Understanding immunity to influenza B viruses for a rationally designed universal vaccine [ 1/1/2021 - 12/31/2025 ]

Research Grant

Brief description Influenza B viruses (IBV) circulate annually and are particularly prevalent and severe in children. However, IBV remain largely understudied. Our immune system provides protection against IBV via a variety of mechanisms. This study will characterize the immunity to IBV and dissect host-virus interactions which provide protection from IBV infection. This project will inform the rational design of novel vaccines eliciting universal immunity to IBV, with an ultimate goal of controlling IBV.

Funding Amount $645,205

Funding Scheme Investigator Grants

Chief Investigator Dr Marios Koutsakos

Notes Emerging Leadership 1